These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33662168)

  • 1. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
    Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
    Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma.
    Aron JL; Akbari O
    Allergy; 2017 Aug; 72(8):1148-1155. PubMed ID: 28160290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
    Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
    Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T-cell costimulator-inducible T-cell costimulator ligand interaction.
    Rigas D; Lewis G; Aron JL; Wang B; Banie H; Sankaranarayanan I; Galle-Treger L; Maazi H; Lo R; Freeman GJ; Sharpe AH; Soroosh P; Akbari O
    J Allergy Clin Immunol; 2017 May; 139(5):1468-1477.e2. PubMed ID: 27717665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-κB in allergic rhinitis patients.
    Fan XL; Zeng QX; Li X; Li CL; Xu ZB; Deng XQ; Shi J; Chen D; Zheng SG; Fu QL
    Stem Cell Res Ther; 2018 Jun; 9(1):170. PubMed ID: 29921316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.
    Alves GF; Stoppa I; Aimaretti E; Monge C; Mastrocola R; Porchietto E; Einaudi G; Collotta D; Bertocchi I; Boggio E; Gigliotti CL; Clemente N; Aragno M; Fernandes D; Cifani C; Thiemermann C; Dianzani C; Dianzani U; Collino M
    Front Immunol; 2022; 13():992614. PubMed ID: 36119089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
    Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
    Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
    Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis.
    Fu QL; Chow YY; Sun SJ; Zeng QX; Li HB; Shi JB; Sun YQ; Wen W; Tse HF; Lian Q; Xu G
    Allergy; 2012 Oct; 67(10):1215-22. PubMed ID: 22882409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells mediated by small extracellular vesicles derived from MSCs attenuated the ILC2 activity via PGE2 in patients with allergic rhinitis.
    Liu XQ; Peng YQ; Huang LX; Li CG; Kuang PP; Chen DH; Wu ZC; He BX; Zhou ZR; Fu QL
    Stem Cell Res Ther; 2023 Jul; 14(1):180. PubMed ID: 37488601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.
    Maazi H; Patel N; Sankaranarayanan I; Suzuki Y; Rigas D; Soroosh P; Freeman GJ; Sharpe AH; Akbari O
    Immunity; 2015 Mar; 42(3):538-51. PubMed ID: 25769613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.
    Paclik D; Stehle C; Lahmann A; Hutloff A; Romagnani C
    Eur J Immunol; 2015 Oct; 45(10):2766-72. PubMed ID: 26249010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
    Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
    Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Flow Cytometry Unveils Distinct Immune Cell Subsets in Inducible T Cell Co-Stimulator Ligand (ICOSL)- and ICOS-Knockout Mice during Experimental Autoimmune Encephalomyelitis.
    Raineri D; Abreu H; Vilardo B; Kustrimovic N; Venegoni C; Cappellano G; Chiocchetti A
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction.
    Nayar S; Pontarini E; Campos J; Berardicurti O; Smith CG; Asam S; Gardner DH; Colafrancesco S; Lucchesi D; Coleby R; Chung MM; Iannizzotto V; Hunter K; Bowman SJ; Carlesso G; Herbst R; McGettrick HM; Browning J; Buckley CD; Fisher BA; Bombardieri M; Barone F
    Commun Biol; 2022 May; 5(1):413. PubMed ID: 35508704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICOS promotes group 2 innate lymphoid cell activation in lungs.
    Kamachi F; Isshiki T; Harada N; Akiba H; Miyake S
    Biochem Biophys Res Commun; 2015 Aug; 463(4):739-45. PubMed ID: 26049110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER-stressed MSC displayed more effective immunomodulation in RA CD4
    Wei J; Ouyang X; Tang Y; Li H; Wang B; Ye Y; Jin M; Al Azab M; Li W; Li X
    Mod Rheumatol; 2020 May; 30(3):509-516. PubMed ID: 31370727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.